Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasma Cell (Epstein-Barr Virus-Infected) (EBV-infected Plasma Cell)
- Target
- EBV-infected Plasma Cell
- Molecular classification
- B lymphocyte, Plasma cell, Virus-infected cell
01
Overview
Plasma cells are terminally differentiated B lymphocytes responsible for antibody production. Epstein-Barr virus (EBV)-infected plasma cells are a rare but clinically significant entity, particularly in immunocompromised patients. EBV infection in plasma cells can be associated with plasmablastic lymphoma and, less commonly, other plasma cell neoplasms. Detection is typically performed via EBER in situ hybridization (ISH).
- Other names
- EBV+ Plasma CellEpstein-Barr Virus Infected Plasma CellEBER positive Plasma Cell
02
Biological functions
Antibody production (in the uninfected state)Viral replicationImmune evasion
03
Disease associations
Plasmablastic lymphomaMultiple myelomaExtramedullary plasmacytomaEBV-associated lymphoproliferative disorders
04
Safety considerations
Risk of aggressive B-cell lymphomasPotential for progression to multiple myelomaChallenges in distinguishing from other plasma cell neoplasms
05
Biomarkers
EBER ISH positivityCD138 expressionCD20 negativityEBV viral load
Beyond the preview
Go deeper on Plasma Cell (Epstein-Barr Virus-Infected) (EBV-infected Plasma Cell).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Plasma Cell (Epstein-Barr Virus-Infected) (EBV-infected Plasma Cell).